Wednesday, December 9 , 2020

Program 13:00, Close 14:00 (HK Time / GMT +8)

新型冠狀病毒資訊站（第二十五集）：與劉遠立博士和李雪博士對話 ［普通話］

世界衛生組織在1月30日確實新型冠狀病毒為全球醫療緊急事件。各國醫療專家警告若不盡快採取預防措施，新型冠狀病毒有可能快速傳染。在國際關注下，不少市民亦十分關注，我們應該如何分辨那些是新聞，那些是謠言呢？亞洲協會香港中心會在今次的新型冠狀病毒資訊站會與劉遠立博士和李雪博士對話，並為大家提供最新疫情研究及進展！

On January 30, the World Health Organization declared a global health emergency on the spread of the novel coronavirus (Covid-19) that originated in Wuhan, China. Healthcare experts have warned that Covid-19 could rapidly spread, if not properly contained, and many governments around the world have begun to take precautionary measures to ensure public health safety. Amid the international concern and heightened fears about the disease, what is fact and what is fiction? The Asia Society Hong Kong Center brings you regular updates on the coronavirus story in Hong Kong that has reverberations elsewhere in the world. We are pleased to present on-the-ground public health experts and internationally renowned specialists with the latest facts and evidence-based findings regarding this epidemic outbreak. In episode 25, hear from Dr. Yuanli Liu from Peking Union College School of Public Health, moderated by Dr. Shirley Li from Department of Medicine and Department of Pharmacology and Phamacy, HKU.

Dr. Yuanli Liu, Dean of Peking Union Medical College School of Public Health, Dean of Chinese Academy of Medical Sciences and President of Chinese Ageing Well Association. He is also a Distinguished Expert for “the Thousand Talents Plan” initiated by Organization Department of the Central Committee.

Dr. Liu aims at establishing a modernized and globalized school of public health, which promotes scientific research of high quality and nurtures professionals with leadership. He engaged in instruction and research at Harvard University in the areas of global health policy and management from 1994 to 2013. He is one of the founders of “Health System Analysis” and the doctoral advisor in this discipline. Appointed as the director of HSPH China Initiative in 2015, he has been leading the academic communication and collaboration in the field of healthcare and social development between China and Harvard University ever since.

Dr. Liu has made great contribution to the research and policy consulting on a series of crucial issues regarding healthcare reforms and developments in China. He has published over 100 journal articles in national and international journals, as well as 6 academic books in Chinese and English, including Building a Healthy Society for All. He also serves as the group leader of strategic planning on “Healthy Beijing 2020” project and the research project on “Development of Healthy China and Improvement of Policy towards 2050”. 

Dr Shirley Li, Assistant Professor at the Department of Medicine and Department of Pharmacology and Pharmacy, University of Hong Kong (HKU). Before joining HKU, she obtained Master of Medicine at Peking Union Medical College, Tsinghua University and a PhD in Public Health at the Chinese University of Hong Kong.

Dr Li’s primary research interests lie in health technology assessment (HTA), health economics and real-world outcome (HEOR) research using decision-analytic models healthcare big data. Dr Li has expertise in big-data based pharmacoepidemiology, cost-effectiveness assessment for healthcare interventions, and health policy evaluation. Since joining HKU in 2014, Dr Li has led and contributed to many HERO projects, all of which involves dynamic interactions with local and international academic collaborators, the local government, industry partners, NGOs and other key opinion leaders. Dr Li’s recent research focuses on the projection of healthcare expenditure on mental health disorders across the lifespan and the development of value-based risk-sharing model for innovative and curative therapies. (Moderator)

In collaboration with:

Register Here: https://ticketing.asiasociety.org.hk/Index?eventId=a0l2v000009PGrI 

Got Questions? Ask here: https://app.sli.do/event/ajp93rl2